Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Anti-venoms Serum in Africa

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Any patient over 5 years old (inclusive) visiting at a participating center for a snake bite with or without confirmed envenoming~* Informed consent to research~Exclusion Criteria:~* Patient refusal~* Under 5 year-old~* Antivenom serum administration before the arrival in the participating center~* History of severe allergic reactions to antivenom serum

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients bitten by a snake (Type: None): Any patient over 5 years old going to a participating center for curative care following a snake bite.~Participation to the study does not change usual follow-up of patients. Antivenom serum Inoserp Pan-Africa® injection will be decided according to the clinical evaluation of the patient.

Based on this trial design, predict the completion outcome and termination type (if applicable).